| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $549.8M | — | +30.8% |
| Cost of Revenue | $468.0M | — | +36.0% |
| Gross Profit | $81.8M | — | +7.4% |
| R&D Expense | $6.2M | — | -5.3% |
| SG&A Expense | $36.2M | — | +2.1% |
| Operating Income | $28.2M | — | +3.6% |
| Pre-tax Income | $20.9M | — | -0.2% |
| Income Tax | $1.5M | — | -52.8% |
| Net Income | $19.4M | — | +9.5% |
| EPS (Basic) | $0.93 | — | +9.4% |
| EPS (Diluted) | $0.92 | — | +8.2% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.2M | +18.3% | +3.5% |
| Accounts Receivable | $267.2M | +19.9% | +21.8% |
| Inventory | $493.7M | +7.0% | +12.3% |
| Current Assets | $875.7M | +10.9% | +15.4% |
| Total Assets | $1.88B | +4.1% | +7.1% |
| Current Liabilities | $288.5M |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | -127.8% |
| Capital Expenditures | $15.3M | — | +24.1% |
| Investing Cash Flow | -$15.3M | — | +26.0% |
| Financing Cash Flow | $22.4M | — | +543.5% |
| Free Cash Flow | -$19.6M | — | -716.0% |
| +8.0% |
| Long-term Debt | $491.7M | +6.7% | +8.5% |
| Stockholders' Equity | $957.0M | +1.5% | +7.8% |